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Abstract	
	
Objective	To	assess	the	association	of	the	Medication	Regimen	Complexity	Index	(MRCI)	with	psychiatric	hospital	readmission	rate	and	time	to	hospital	readmission	in	a	high-utilization	cohort.				
Methods		Adult	patients	admitted	between	July	2012	and	March	2014	were	identified	if	they	had	been	discharged	from	an	adult	inpatient	psychiatry	service	with	greater	than	or	equal	to	five	psychiatric	readmissions	or	at	least	one	30-day	readmission	in	this	time	frame.	Dosage	form,	frequency	of	dosing,	and	additional	usage	directions	for	each	medication	on	each	discharge	were	collected	from	the	electronic	pharmacy	database,	and	complexity	of	the	medication	regimen	was	determined	using	the	65-item	validated	Microsoft	Access	Version	1.0	medication	regimen	complexity	electronic	data	capture	tool.	Statistical	analysis	was	conducted	using	statistical	software	R,	version	3.2.2,	and	Pearson’s	correlation	was	used	to	calculate	correlations.		
Results	A	total	of	168	patients	were	identified.	MRCI	for	psychotropic	medications	and	total	MRCI	at	first	discharge	were	both	found	to	be	unrelated	to	the	days	between	first	discharge	and	first	readmission	(r=0.065,	p=0.40	and	r=0.0054,	p=0.94,	respectively).	Average	total	MRCI	was	unrelated	to	average	days	between	each	readmission	(r=0.064,	p=0.41),	but	a	statistically	significant	association	was	found	between	average	MRCI	for	psychotropic	medications	and	average	days	between	each	readmission	(r=0.16,	p=0.044).	Both	average	MRCI	for	psychotropic	medications	and	average	total	MRCI	were	found	to	be	unrelated	to	readmission	rate	(r=0.11,	p=0.16	and	r=0.14,	p=0.07,	respectively).	Average	psychotropic	medication	count	was	found	to	be	unrelated	to	readmission	rate	(r=0.11,	p=0.17)	but	had	a	statistically	significant	association	with	average	time	to	readmission	(r=0.18,	p=0.019).			
Conclusions	A	more	complex	psychotropic	medication	regimen	and	a	higher	psychotropic	medication	count	at	discharge	may	result	in	a	shorter	time	to	readmission	in	a	high-utilizer,	adult	psychiatric	population.	The	impact	of	other	medication-related	factors	and	the	clinical	significance	of	the	use	of	the	MRCI	must	be	determined	in	larger,	long-term	clinical	trials.		
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Introduction	In	recent	years,	decreasing	readmission	rates	has	become	a	priority	for	hospitals	throughout	the	United	States.1-4	Preventable	hospital	readmissions	have	been	estimated	to	cost	more	than	$12	billion	annually,	leading	the	Centers	for	Medicare	and	Medicaid	(CMS)	to	incentivize	hospitals	to	focus	on	decreasing	30-day	readmissions	in	specific	high-risk	disease	states,	including	acute	myocardial	infraction,	heart	failure,	and	pneumonia.1,2	In	2012,	CMS	began	reducing	Medicare	payments	for	hospitals	with	excess	readmissions	through	the	Hospital	Readmissions	Reduction	Program	(HRRP),	which	was	created	to	provide	financial	incentives	to	hospitals	to	reduce	costly	and	unnecessary	readmissions	through	coordinating	transitions	of	care	and	improving	the	quality	of	patient	care.1	The	implementation	of	these	types	of	strategies	to	prevent	hospital	readmissions	has	led	to	increased	research	efforts	focusing	on	measuring	the	impact	that	they	have	on	reducing	hospital	readmission	rates.		Although	several	studies	have	been	researched	the	prevention	of	hospital	readmissions	for	various	medical	diagnoses,	such	as	heart	failure	and	diabetes,	there	is	little	research	that	exists	in	regards	to	psychiatric	readmissions	and	even	less	on	the	role	that	medication-related	factors	may	play	in	the	readmissions	of	psychiatric	patients.	It	has	been	shown	that	medication	nonadherence	is	a	modifiable	risk	factor	for	rehospitalization	risk	in	the	severely	mentally	ill	population,	with	50%	of	patients	becoming	nonadherent	in	the	first	month	following	discharge.3	Several	medication-related	factors	have	been	associated	with	the	issue	of	nonadherence	and	increased	risk	of	hospitalization,	which	has	led	to	an	interest	in	understanding	how	the	complexity	of	a	medication	regimen	may	affect	patient	outcomes	including	hospital	readmissions.	Studies	have	found	that	increasing	medication	regimen	complexity	is	directly	associated	with	nonadherence,	but	the	contribution	of	the	complexity	of	a	patient’s	medication	regimen	to	readmission	risk	in	psychiatric	patients	has	not	been	extensively	investigated.3,4		The	Medication	Regimen	Complexity	Index	(MRCI)	is	a	validated	65-item	tool	for	quantifying	drug	regimen	complexity	based	on	the	quantity	of	medications,	dosage	form,	dosage	frequency,	and	additional	or	special	instructions.2,5,6	Higher	weights	are	assigned	for	factors	such	as	dosage	forms	with	less	convenient	administration,	strict	time	intervals,	and	any	additional	instructions	such	as	“break/crush	tablet.”	The	MRCI	considers	disease-specific	prescription	medications,	other	prescription	medications,	and	over-the-counter	(OTC)	medications,	and	a	higher	MRCI	score	indicates	higher	complexity.	Although	this	tool	has	been	studied	in	patients	with	various	disease	states,	only	one	study	has	looked	specifically	at	psychiatric	patients,	and	this	study	
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focused	on	elderly	adults	age	65	years	or	older	with	a	diagnosis	of	depression	and	did	not	evaluate	the	impact	of	the	MRCI	on	time	to	readmission	or	readmission	rate.4		Our	study	sought	to	utilize	the	electronic	MRCI	coding	tool	to	evaluate	whether	or	not	an	association	exists	between	the	MRCI	and	time	to	readmission	as	well	as	readmission	rate	in	a	high-utilizer,	adult	psychiatric	patient	population.	We	hypothesized	that	a	higher	total	MRCI	would	result	in	a	shorter	average	time	to	readmission	and	a	higher	overall	readmission	rate,	as	this	would	suggest	that	the	more	complex	a	patient’s	entire	medication	regimen	is,	the	more	likely	they	are	to	be	readmitted	to	the	hospital	faster	and	more	frequently.		
Objective	The	aim	of	this	study	is	to	determine	if	an	association	exists	between	the	Medication	Regimen	Complexity	Index	(MRCI)	and	time	to	hospital	readmission	and	hospital	readmission	rate	in	a	high-utilizer,	adult	psychiatric	population.	The	findings	of	this	study	may	aid	in	informing	avenues	for	future	research	and	the	development	of	targeted	clinical	pharmacy	interventions	to	reduce	the	risk	of	hospital	readmissions	and	associated	costs.	
	
Methods	
	
Study	Design	
	This	study	was	a	single-site,	retrospective	study	approved	by	the	University	of	North	Carolina	(UNC)	at	Chapel	Hill	Institutional	Review	Board.	Patients	admitted	between	July	2012	and	March	2014	were	included	if	they	were	age	18	years	or	older	and	were	identified	as	a	high-utilizer	of	inpatient	psychiatric	services,	which	was	defined	as	having	been	discharged	from	an	adult	inpatient	psychiatry	service	at	UNC	Medical	Center	with	greater	than	or	equal	to	five	psychiatric	readmissions	or	at	least	one	30-day	readmission	in	this	time	frame.	Patients	were	excluded	from	this	study	if	they	were	younger	than	18	years	of	age	and/or	were	discharged	from	and	readmitted	to	facilities	other	than	UNC	Medical	Center	psychiatric	services.		
	
Procedures	
	Patient	data	was	collected	through	the	use	of	the	electronic	hospital	and	pharmacy	databases	and	the	electronic	medical	record	system.	Demographics,	number	and	time	to	readmissions,	length	of	stay,	and	number	and	type	of	medications	for	each	hospital	discharge	and	readmission	were	collected.	Dosage	form,	frequency	of	dosing,	and	additional	usage	directions	for	each	medication	on	
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each	hospital	discharge	were	collected	from	the	electronic	pharmacy	database	to	determine	the	complexity	of	the	medication	regimen,	which	was	computed	using	the	65-item	validated	Microsoft	Access	Version	1.0	medication	regimen	complexity	electronic	data	capture	tool	by	the	University	of	Colorado	Skaggs	School	of	Pharmacy	and	Pharmaceutical	Sciences.	The	electronic	data	capture	tool	used	for	coding	is	publically	available	online.5	A	screenshot	of	the	main	screen	of	the	tool	is	provided	in	Appendix	1.			For	each	hospital	discharge,	an	MRCI	was	computed	for	three	separate	medication	categories	(psychotropic	medications,	other	prescription	medications,	and	OTC	medications)	based	on	the	discharge	medication	list.	The	three	scores	were	then	combined	to	calculate	the	total	MRCI	score	for	that	discharge.	An	average	total	MRCI	score	was	computed	for	each	patient	by	averaging	the	total	MRCI	scores	from	each	hospital	discharge,	and	an	average	MRCI	score	for	each	of	the	three	medication	categories	was	also	computed	by	averaging	the	MRCI	scores	for	each	medication	category	from	each	hospital	discharge.		The	medication	count	for	each	of	the	three	medication	categories	at	first	hospital	discharge	as	well	as	the	total	medication	count	at	first	hospital	discharge	were	recorded.	The	average	total	medication	count	for	each	patient	and	the	average	medication	count	for	each	medication	category	were	also	computed	and	recorded.	To	determine	the	time	to	readmission,	the	number	of	days	between	first	hospital	discharge	and	first	hospital	readmission	was	calculated	for	each	patient,	and	the	average	time	to	readmission	for	each	patient	was	determined	by	averaging	the	number	of	days	between	each	hospital	discharge	and	readmission.	The	number	of	hospital	readmissions	was	totaled	for	each	patient	to	determine	the	patient’s	readmission	rate.			
 
Data	Analysis	
	All	data	collection	was	documented	on	a	data	collection	form	and	entered	into	a	Microsoft	Excel	spreadsheet.	All	data	was	recorded	without	patient	identifiers	and	was	maintained	confidentially.	Descriptive	statistics	were	used	to	analyze	baseline	characteristics.	Further	statistical	analysis	of	was	conducted	using	statistical	software	R,	version	3.2.2,	and	Pearson’s	correlation	was	utilized	to	calculate	correlations.	
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Results	A	total	of	174	patients	were	identified	to	be	included	in	this	study.	Six	patients	were	excluded	as	they	did	not	fully	meet	inclusion	criteria.	168	patients	were	included	in	the	data	analysis	(Figure	1).	Table	1	provides	demographic	information	about	the	study	participants.	The	mean	age	was	41.3	years,	and	the	majority	of	the	patients	were	female	(56%).	90%	had	psychiatric	readmissions	within	30	days	and	12%	had	five	or	more	psychiatric	admissions.	Ten	percent	of	patients	had	both	five	or	more	psychiatric	admissions	and	readmissions	within	30	days,	and	2%	had	five	or	more	psychiatric	admissions	without	readmissions	within	30	days.			
	
Figure	1.	Screening	of	Study	Participants	
	
	
	
	
	
	
	
	
	
	
MRCI	Score:	Psychotropic	Medications	At	first	hospital	discharge,	the	average	MRCI	for	psychotropic	medications	was	6.86	(range:	0	to	19)	and	was	unrelated	to	the	days	between	first	discharge	and	first	readmission	(r=0.065,	p=0.40).	The	average	MRCI	for	psychotropic	medications	for	all	readmissions	was	7.09	(range:	0	to	17.5),	and	a	statistically	significant	association	was	found	between	this	score	and	the	average	days	between	each	readmission	(r=0.16,	p=0.044).	There	was	no	statistically	significant	association	between	the	average	MRCI	for	psychotropic	medications	and	readmission	rate	(r=0.11,	p=0.16).		
	
MRCI	Score:	Other	Prescription	Medications	At	first	hospital	discharge,	the	average	MRCI	for	other	prescription	medications	was	6.01	(range:	0	to	46),	and	for	all	hospital	readmissions,	the	average	MRCI	for	other	prescription	medications	was	5.90	(range:	0	to	38.25).	No	significant	association	was	found	between	the	MRCI	at	first	hospital	discharge	for	other	prescription	medications	and	the	time	to	first	readmission	(r=-0.00028,	
n	=	174	identified	 n	=	168	eligible	
n	=	152	Readmissions	within	30	days	
n	=	19	>5	readmissions	
n	=	16	WITH	readmissions	within	30	days	 n	=	3	NO	readmissions	within	30	days	
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p=1.00).	There	were	also	no	significant	associations	between	the	average	MRCI	for	other	prescription	medications	for	all	readmissions	and	the	average	days	between	each	readmission	or	readmission	rate	(r=-0.03,	p=0.70	and	r=0.049,	p=0.53,	respectively).			
MRCI	Score:	Over-the-Counter	(OTC)	Medications		At	first	hospital	discharge,	the	average	MRCI	for	OTC	medications	was	2.53	(range:	0	to	19.5),	and	for	all	hospital	readmissions,	the	average	MRCI	for	OTC	medications	was	2.98	(range:	0	to	18.9).	No	significant	association	was	found	between	the	MRCI	at	first	hospital	discharge	for	OTC	medications	and	the	time	to	first	readmission	(r=-0.047,	p=0.54).	A	statistically	significant	association	was	found	between	the	average	MRCI	for	OTC	medications	for	all	readmissions	and	readmission	rate	(r=0.17,	p=0.029),	but	there	was	no	significant	association	with	the	average	days	between	each	readmission	(p=0.059,	p=0.44).		
MRCI	Score:	Total	At	first	hospital	discharge,	the	average	total	MRCI	was	15.36	(range:	0	to	62.5),	and	for	all	hospital	readmissions,	the	average	total	MRCI	was	16.00	(range:	0	to	57.75).	There	was	no	significant	association	between	the	total	MRCI	at	first	discharge	and	the	days	between	first	discharge	and	first	readmission	(r=0.0054,p=0.94).	There	was	also	no	significant	association	between	the	average	total	MRCI	for	all	readmissions	and	the	average	days	between	each	readmission	or	readmission	rate	(r=0.064,	p=0.41	and	r=0.14,	p=0.07,	respectively).	
	
Medication	Count		There	was	a	statistically	significant	association	between	the	average	psychotropic	medication	count	(2.66,	range:	0	to	6)	for	all	readmissions	and	the	average	time	to	readmission	(r=0.18,	r=0.019).	No	other	significant	associations	were	found	regarding	medication	count.			
	A	summary	of	these	findings	can	be	found	in	Table	2	and	3.	
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Table	1.	Baseline	Characteristics		
 
Patient	Characteristic	 N	(%)	
Gender								Male								Female	 	74	(44)	94	(56)	
Race	
							Caucasian								African	American								Asian								Other	
	109	(65)	42(25)	4(2)	13(8)	
Age								<25								25-44								45-64								>65	
	30	(18)	71	(42)	57	(34)	10	(6)	
Diagnoses							Bipolar								Depressive	disorder							Mood	disorder							Schizophrenia							Schizoaffective	disorders							Substance-related	disorders							Other	
	31	(19)	52	(31)	29	(17)	23	(14)	24	(14)	25	(15)	55	(33)	
High-Utilizer	Criteria							Psychiatric	readmission	within	30	days							>5	psychiatric	readmissions							>5	psychiatric	readmissions	and	psychiatric	readmissions	within	30	days							>5	psychiatric	readmissions	without	psychiatric	readmissions	within	30	days	
	152	(90)	19	(12)	16	(10)	3	(2)	
Length	of	stay	(days)							0-4							5-9						10-14						15-19						20	or	more		
	125	(25)	206	(41)	79	(16)	29	(6)	57	(11)	
Time	between	readmissions	(days)						0-5						6-10						11-15						16-20						21-25						26-30						31-60						61-90						91-120						>120	
	68	(20)	50	(15)	41	(12)	23	(7)	29	(9)	9	(3)	29	(9)	26	(8)	17	(5)	45	(13)	
Number	of	psychiatric	readmissions						2						3						4						5						6						7						8						9	
	86	(51)	45	(27)	21	(13)	12	(7)	5	(3)	1	(1)	0	(0)	1	(1)	
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Table	2.	Correlation	Data	
	
	
Variables	
Days	between	first	
discharge	and	first	
readmission	
Average	days	
between	each	
readmission	
Readmission		
rate	
MRCI	at	first	discharge											Psychotropic											Other	Rx											OTC											Total	
	r=0.065,	p=0.40	r=-0.00028,	p=1.00	r=-0.047,	p=0.54	r=0.0054,	p=0.94		
	 	 	 	
Average	MRCI											Psychotropic											Other	Rx											OTC											Total	
		 	r=0.16,	p=0.044	r=-0.03,	p=0.70	r=0.059,	p=0.44	r=0.064,	p=0.41	
	r=0.11,	p=0.16	r=0.049,	p=0.53	r=0.17,	p=0.029	r=0.14,	p=0.07		
Medication	count	at	first	discharge											Psychotropic											Other	Rx											OTC											Total		
	r=0.096,	p=0.22	r=-0.0092,	p=0.91	r=-0.041,	p=0.60	r=0.063,	p=0.42	
	 	
Average	medication	count											Psychotropic											Other	Rx											OTC											Total		
	 	r=0.18,	p=0.019	r=-0.04,	p=0.61	r=0.036,	p=0.64	r=0.052,	p=0.50	
	r=0.11,	p=0.17	r=0.05,	p=0.52	r=0.14,	p=0.063	r=0.13,	p=0.091	
 
 
Table	3.	MRCI	Scores	and	Medication	Counts		
  
Variables	 Average	(range)	at	first		hospital	discharge	
Total	average	(range)	for		
all	hospital	readmissions	
MRCI												Psychotropic											Other	Rx											OTC											Total	
	6.86	(0-19)	6.01	(0-46)	2.53	(0-19.5)	15.36	(0-62.5)	
	7.09	(0-17.5)	5.90	(0-38.25)	2.98	(0-18.9)	16.00	(0-57.75)	
Medication	count												Psychotropic											Other	Rx											OTC											Total	
	2.63	(0-8)	2.14	(0-15)	0.99	(0-8)	5.76	(0-22)	
	2.66	(0-6)	2.07	(0-12.67)	1.09	(0-6.67)	5.83	(0-18)	
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Discussion	The	primary	finding	of	this	study	was	that	a	statistically	significant	association	exists	between	the	average	MRCI	for	psychotropic	medications	and	the	average	time	to	readmission	as	well	as	the	average	psychotropic	medication	count	and	the	average	time	to	readmission.	These	findings	suggest	that	a	more	complex	psychotropic	medication	regimen	and	a	higher	psychotropic	medication	count	at	discharge	may	result	in	a	shorter	time	to	readmission	in	a	high-utilizer,	adult	psychiatric	population.	Although	one	may	suspect	that	the	complexity	of	a	patient’s	entire	medication	regimen	and	the	total	medication	count	would	contribute	to	a	faster	time	to	readmission,	this	study	found	that	in	this	patient	population,	it	was	only	the	complexity	of	the	disease-specific	medication	regimen	as	well	as	the	disease-specific	medication	count	that	impacted	the	time	to	readmission.	Possible	explanations	for	this	finding	may	include	adverse	events	of	psychotropic	medications	affecting	cognition,	inability	to	afford	medications	post-discharge,	or	lack	of	social	support	to	assist	in	adhering	to	a	complex	medication	regimen.		The	MRCI	electronic	coding	tool	was	created	on	the	basis	that	multiple	and	unique	dosage	formulations,	dosing	frequencies,	and	additional	instructions	likely	complicate	a	patient’s	ability	to	maintain	appropriate	and	consistent	medication	administration	practices.	However,	in	the	case	of	psychiatric	patients,	the	demands	of	maintaining	medication	adherence	may	be	even	further	complicated	by	other	factors,	such	as	unstable	mental	capacity,	social	stigma	surrounding	psychiatric	diagnoses,	etc.3	Our	study	did	not	evaluate	these	additional	factors,	which	we	recognize	may	be	a	limitation	of	our	study.	To	date,	there	are	limited	studies	that	have	investigated	the	association	of	the	MRCI	with	hospital	readmissions	in	a	broad	psychiatric	patient	population.		The	findings	of	our	study	are	broadly	generalizable	and	can	be	applied	to	a	holistic	psychiatric	patient	population	as	the	study	included	adults	age	18	years	or	older	as	well	as	a	variety	of	psychiatric	diagnoses,	such	as	bipolar	disorder,	schizophrenia,	substance-related	disorders,	etc.		Based	on	the	significant	associations	found,	the	results	suggest	a	need	for	more	focused,	thorough	review	of	a	patient’s	disease-specific	medication	regimen	during	the	transitions	of	care	process	to	reduce	the	risk	of	medication-related	factors	and	lengthen	the	time	to	subsequent	readmissions.	Although	these	findings	should	not	undervalue	the	importance	of	reviewing	the	entire	medication	regimen	as	a	whole,	they	propose	that	healthcare	professionals	could	potentially	spend	less	time	and	increase	efficiency,	while	also	maintaining	efficacy,	by	focusing	mainly	on	the	disease-specific	medication	regimen	that	a	patient	is	being	discharged	on.	By	implementing	a	tool	like	the	MRCI	into	the	electronic	medical	record,	members	of	the	patient	care	team	would	be	able	to	more	easily	identify	those	patients	who	would	benefit	from	increased	attention	and	targeted	services	throughout	the	transitions	of	care	process	by	focusing	their	efforts	on	patients	with	a	
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complex	medication	list	that	has	a	high	disease-specific	MRCI	score	and/or	high	disease-specific	medication	count.		As	the	medication	experts	of	the	patient	care	team,	pharmacists	are	positioned	as	the	ideal	healthcare	professional	to	take	part	in	this	intervention.	At	UNC	Medical	Center,	pharmacists	are	currently	involved	in	obtaining	medication	histories,	performing	medication	reconciliation,	counseling	patients	on	discharge	medications,	and	participating	in	a	variety	of	transitions	of	care	services,	such	as	hospital	follow-up	visits	in	ambulatory	care	clinics	and	communication	with	providers	regarding	any	outstanding	or	notable	issues	upon	discharge.	Therefore,	pharmacists	are	already	accustomed	to	the	importance	of	these	processes	and	services.	While	some	transitions	of	care	services	do	occur	by	pharmacy	staff	for	inpatient	psychiatric	services,	these	types	of	services	have	not	yet	been	fully	implemented	in	processes	bridging	the	patients	to	outpatient	services	or	within	the	ambulatory	care	settings	at	this	time.	Furthermore,	with	the	extensive	pharmacotherapy	knowledge	and	experience	that	pharmacists	have,	they	are	able	to	effectively	and	efficiently	identify	opportunities	upon	medication	review	that	could	reduce	the	complexity	of	a	patient’s	medication	regimen,	such	as	switching	to	a	less	complex	dosage	formulation	or	reducing	administration	instructions.	In	addition,	pharmacist	review	would	also	focus	on	providing	more	targeted	patient	education	and	counseling	to	assist	patients	in	being	more	comfortable	and	less	confused	about	the	medications	that	they	are	being	discharged	on	in	hopes	of	increasing	adherence	and	therefore	preventing	readmission	to	the	hospital.		The	only	variable	that	was	found	to	have	a	significant	association	with	readmission	rate	was	the	average	MRCI	score	for	OTC	medications,	which	conveys	that	in	this	study	population,	a	more	complex	OTC	medication	regimen	was	associated	with	increased	readmission	rate.	Therefore,	although	it	may	not	impact	30-day	readmissions,	having	the	pharmacist	also	focus	the	medication	review	and	patient	education	on	OTC	medications	may	result	in	a	slower	time	to	readmission.	The	interpretation	of	this	association	may	not	be	as	robust	as	the	other	significant	findings	of	this	study	due	to	the	variability	and	uncertainty	surrounding	OTC	medications.	For	instance,	it	is	easier	to	track	if	and	when	a	patient	picked	up	their	disease-specific	or	other	prescription	medications	at	their	pharmacy,	but	there	is	no	such	certainty	with	OTC	medications	aside	from	patient	report.			 There	are	several	limitations	to	this	study.	First,	the	definition	of	a	high-utilizer	cohort	for	this	study	may	have	skewed	the	interpretation	of	the	study	results.	We	sought	to	evaluate	a	high-utilizer	cohort,	which	was	defined	as	patients	having	five	or	more	psychiatric	admissions	or	at	least	one	30-day	readmission.	However,	the	majority	of	the	study	population	(n=152,	90%)	qualified	due	to	having	at	least	one	30-day	readmission	while	only	19	of	the	168	patients	(12%)	qualified	due	to	
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having	five	or	more	admissions.	Additionally,	78%	of	the	patients	had	only	two	to	three	psychiatric	admissions,	and	only	5%	of	the	patients	included	had	six	or	more	psychiatric	admissions.	This	could	be	a	contributing	factor	as	to	why	no	significant	associations	were	found	with	readmission	rate	aside	from	the	average	MRCI	score	for	OTC	medications.	Additionally,	the	study	focused	solely	on	evaluating	the	complexity	of	a	patient’s	discharge	medication	list	and	how	the	complexity	may	contribute	to	time	to	readmission	or	readmission	rate.	We	did	not	further	investigate	whether	or	not	patients	actually	consumed	the	medications	after	discharge	or	other	medication-related	factors,	such	as	inability	to	afford	medications,	adverse	side	effects	leading	to	early	discontinuation,	etc.,	and	if	these	factors	contributed	to	a	faster	time	to	readmission	or	an	increased	readmission	rate.	Our	study	also	only	evaluated	readmissions	to	the	inpatient	psychiatric	service	and	not	overall	medical	hospital	readmissions	and	the	effect	that	a	patient’s	comorbidities	may	have	on	readmission	risk.	It	is	pertinent	for	future	studies	to	take	these	issues	into	consideration	to	gain	a	more	comprehensive	understanding	of	what	role	additional	medication-related	factors	play	in	the	issue	of	hospital	readmissions.		Furthermore,	the	MRCI	score	for	each	patient	was	hand-coded	by	one	study	investigator	using	the	Microsoft	Access	database.	This	process	can	be	time-consuming	and	cumbersome	and	can	also	result	in	human	error.	Automated	coding	in	a	patient’s	electronic	medical	record	is	much	more	clinically	relevant	and	practical	in	the	inpatient	practice	setting.	It	has	been	shown	that	incorporating	an	automated	algorithm	into	the	electronic	medical	record	system	reduces	individual	coding	error,	and	this	would	also	allow	for	pharmacists	and	other	members	of	the	patient	care	team	to	quickly	identify	patients	with	highly	complex	medication	regimens	so	that	they	can	introduce	meaningful	interventions	in	an	efficient	manner.4			
Conclusion	A	more	complex	psychotropic	medication	regimen	and	a	higher	psychotropic	medication	count	at	discharge	may	result	in	a	shorter	time	to	readmission	in	a	high-utilizer,	adult	psychiatric	population.	Future	research	with	the	MRCI	in	the	psychiatric	population	should	focus	on	evaluating	the	impact	of	using	an	automated	MRCI	coding	tool	as	an	additional	factor	to	identify	patients	for	targeted	pharmacist	transitions	of	care	services	and	evaluating	which	components	of	the	MRCI	(dosage	formulation,	dosing	frequency,	additional	instructions)	significantly	contribute	to	time	to	readmission	and	readmission	rate.			
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